| Literature DB >> 26236101 |
Yue Long1, Xin Dong2, Yawei Yuan3, Jinqiang Huang3, Jiangang Song4, Yumin Sun3, Zhijie Lu3, Liqun Yang4, Weifeng Yu3.
Abstract
The study examined the global metabolic and some biochemical changes in rats with cholestasis induced by bile duct ligation (BDL). Serum samples were collected in male Wistar rats with BDL (n = 8) and sham surgery (n = 8) at day 3 after surgery for metabolomics analysis using a combination of reversed phase chromatography and hydrophilic interaction chromatography (HILIC) and quadrupole-time-of-flight mass spectrometry (Q-TOF MS). The serum levels of malondialdehyde (MDA), total antioxidative capacity (T-AOC), glutathione (GSH) and glutathione disulfide (GSSG), the activities of superoxide dismutase (SOD) and glutathion peroxidase (GSH-Px) were measured to estimate the oxidative stress state. Key changes after BDL included increased levels of l-phenylalanine, l-glutamate, l-tyrosine, kynurenine, l-lactic acid, LysoPC(c) (14:0), glycine and succinic acid and decreased levels of l-valine, PC(b) (19:0/0:0), taurine, palmitic acid, l-isoleucine and citric acid metabolism products. And treatment with BDL significantly decreased the levels of GSH, T-AOC as well as SOD, GSH-Px activities, and upregulated MDA levels. The changes could be mapped to metabolism of amino acids and lipids, Krebs cycle and glycolysis, as well as increased oxidative stress and decreased antioxidant capability. Our study indicated that BDL induces major changes in the metabolism of all 3 major energy substances, as well as oxidative stress.Entities:
Keywords: HILIC-MS; RPLC-MS; metabolomics; obstructive jaundice; oxidative stress
Year: 2015 PMID: 26236101 PMCID: PMC4512893 DOI: 10.3164/jcbn.14-147
Source DB: PubMed Journal: J Clin Biochem Nutr ISSN: 0912-0009 Impact factor: 3.114
Fig. 1Representative serum RPLC-MS base peak chromatograms (BPC) of sham rats in (A) ESI+ mode and (B) ESI– mode.
Fig. 2Representative serum HILIC-MS base peak chromatograms (BPC) of sham rats in ESI+ mode.
Fig. 3Multivariate analysis of the data from ESI positive ion mode: sham control vs BDL. (A) PCA scores plot (B) PLS-DA scores plot (C) PLS-DA S-plot () sham control, () BDL.
Potential biomarkers and their metabolic pathways
| No. | RT (min) | m/z | Selected ion | Formula | Metabolite | Trenda | Pathway | |
|---|---|---|---|---|---|---|---|---|
| RP | HILIC | |||||||
| ESI+ | ||||||||
| 1 | 1.96 | 14.67 | 166.0872 | [M+H]+ | C9H11NO2 | ↑*** | Amino acid metabolism | |
| 2 | −14.89 | 132.1032 | [M+H]+ | C6H13NO2 | ↓** | Amino acid metabolidm | ||
| 3 | 0.68 | — | 148.06 | [M+H]+ | C5H9NO4 | ↑*** | Amino acid metabolism | |
| 4 | −15.79 | 118.0863 | [M+H]+ | C5H11NO2 | ↓** | Amino acid metabolism | ||
| 5 | 1.03 | 15.23 | 182.0816 | [M+H]+ | C9H11NO3 | ↑** | Amino acid metabolism | |
| 6 | 1.88 | — | 209.0923 | [M+H]+ | C10H12N2O3 | Kynurenine | ↑*** | Lipid metabolism |
| 7 | 0.80 | — | 113.023 | [M+Na]+ | C3H6O3 | ↑* | Glycolysis | |
| 8 | 15.46 | — | 538.3887 | [M+H]+ | C27H56NO7P | PCb (19:0/0:0) | ↓*** | Lipid metabolism |
| 9 | 11.76 | — | 468.3104 | [M+H]+ | C22H46NO7P | LysoPCc (14:0) | ↑* | Lipid metabolism |
| ESI− | ||||||||
| 10 | 0.69 | — | 124.0076 | [M-H]− | C2H7NO3S | Taurine | ↓*** | Amino acid metabolism |
| 11 | 1.11 | — | 120.0295 | [M+FA-H]− | C2H5NO2 | Glycine | ↑* | Amino acid metabolism |
| 12 | 8.91 | — | 255.2318 | [M-H]− | C16H32O2 | Palmitic acid | ↓** | Krebs cycle |
| 13 | 1.02 | — | 191.0192 | [M-H]− | C6H8O7 | Citric acid | ↓** | Krebs cycle |
| 14 | 1.58 | — | 117.0192 | [M-H]− | C4H6O4 | Succinic acid | ↑** | Krebs cycle |
aThe levels of potential biomarkers were labeled with (↑) up-regulation and (↓) down-regulation (*p<0.05; **p<0.01; ***p<0.001). Change trend of BDL-3d group vs control group.
bPC, Phosphatidylcholine.
cLysoPC, Lysophosphatidylcholine.
Fig. 4RPLC-MS and HILIC-MS relative signal intensities for fourteen metabolites: sham control vs BDL. Data are expressed as mean ± SD. Significant differences (p<0.05) existed between sham and BDL for all the metabolites studied. *p<0.05, **p<0.01; ***p<0.001 vs sham control.
Fig. 5Changes in metabolites and metabolic pathways upon BDL. Red: increase; green: decrease; black: no change. See online version figure.
Primary indexes about oxidative stress in serum (mean ± SE)
| Groups | MDA (nmol/ml) | SOD (U/ml) | GSH (mg/L) | GSH-PX | GSSG (µmol/L) | T-AOC (U/ml) |
|---|---|---|---|---|---|---|
| Sham3d group | 4.11 ± 1.07 | 156.03 ± 6.17 | 0.86 ± 2.43 | 271.47 ± 23.94 | 176.58 ± 30.7 | 11.52 ± 0.85 |
| BDL3d group | 8.97 ± 0.83** | 109.84 ± 9.78** | 3.21 ± 0.85** | 189.80 ± 15.49** | 187.63 ± 19.94 | 7.38 ± 1.46* |
*p<0.05, **p<0.01 vs sham control.